Showing 49–64 of 186 resultsSorted by popularity
SLU-PP-332 is a first-in-class small molecule pan-agonist of Estrogen-Related Receptors (alpha, beta, gamma) that mimics exercise-induced metabolic adaptations. It drives mitochondrial biogenesis and fatty acid oxidation without physical exertion, serving as a top-tier exercise mimetic research tool.
Glow(GHKCu50mg+TB10mg+BPC10mg) for research use.
BPC 157 is a stable gastric pentadecapeptide that binds VEGFR2 to stimulate eNOS-driven angiogenesis and modulates the FAK/paxillin pathway for accelerated fibroblast migration. A go-to research compound for evaluating wound healing, tendon repair, and gastrointestinal cytoprotection.
5-Amino-1MQ is a potent and selective NNMT inhibitor that elevates intracellular NAD+ levels, driving mitochondrial biogenesis and fatty acid oxidation. An essential tool for metabolic remodeling and adipose tissue reduction research.
Super Shredder is a high-potency injectable AAS blend combining Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate for combined-action fat loss and lean tissue preservation. Multi-pathway androgen receptor activation with aromatase inhibition.
Semaglutide is a long-acting GLP-1 receptor agonist featuring Aib substitution and fatty acid bioconjugation for DPP-4 resistance and a 7-day half-life. It stimulates glucose-dependent insulin secretion, suppresses glucagon release, and centrally modulates hypothalamic satiety pathways for strong appetite reduction.
Tirzepatide is a peptide that activates both GLP-1 and GIP receptors. It was developed to fight type 2 diabetes by lowering blood sugar levels, boosting insulin sensitivity, and reducing hunger. In addition to cardiovascular benefits, recent trials have demonstrated impressive results when used for weight loss.
Tirzepatide is a peptide that activates both GLP-1 and GIP receptors. It was developed to fight type 2 diabetes by lowering blood sugar levels, boosting insulin sensitivity, and reducing hunger. In addition to cardiovascular benefits, recent trials have demonstrated impressive results when used for weight loss.
Tamoxifen (Nolvadex) is a selective estrogen receptor modulator that acts as a competitive antagonist in breast tissue and at the hypothalamus, triggering LH and FSH release. With a 5-7 day half-life, it is a fundamental tool for estrogen blockade and HPTA restoration research.
TrenMix-200 is a triple-ester Trenbolone blend (Acetate, Enanthate, Hexahydrobenzylcarbonate) at 200mg/ml, providing staggered release kinetics for sustained 19-nor androgenic signaling. Its trienic bond structure precludes aromatization while maintaining extreme receptor affinity.
CJC-1295 without DAC (Modified GRF 1-29) is a tetrasubstituted GHRH analog engineered to stimulate natural, pulsatile growth hormone secretion from the anterior pituitary. Its 30-minute half-life mimics physiological GH rhythms without pituitary receptor downregulation.
Sterile 0.01M Acetic Acid solution for pH-sensitive peptide reconstitution. Maintains peptide stability during dissolution.
GHK Basic Peptides for research use.
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator that penetrates neuronal nuclei to epigenetically modulate gene expression for neurogenesis and telomerase activity. Its signaling effects can persist for 3-6 months, making this a powerful tool for long-term brain function research.
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors.
The data from the trials mentioned that Retatrutide is effective in reducing weight in individuals with nonsyndromic obesity.
5mg *10 vials *1 kits
End of content
End of content
No products in the cart.
